Digital Health Implementation Strategies to Improve Lung Cancer Screening Among Safety-Net Clinics

Summary

The long-term goal of this program of research is to increase the reach of Lung Cancer Screening (LCS) among low-resource healthcare settings and populations. The proposed project, LUNG-IS, is a mixed-methods, pre-post quasi-experimental design conducted in three Utah safety-net healthcare system clinics.

LUNG-IS employs a comprehensive conceptual model with theories, models, and frameworks of implementation and behavioral science, uses rigorous mixed-methods to evaluate factors that influence implementation of LCS, and uses patient navigation to facilitate clinic-community linkages.

LUNG-IS leverages existing pathways to care and Centralized Hub infrastructure that enables eligibility assessment, LCS Shared Decision Making (SDM) with clinical decision support, screening referral, and screening logistics assistance to help overcome barriers to LCS completion. The Centralized Hub model uses ubiquitous technologies (i.e., text messaging/telehealth) to enable patients to be assessed for LCS eligibility, engage in SDM if eligible, and be referred for LCS. For patients who decide to complete LCS, they will be provided patient navigation via Community Health Workers designed to address logistical barriers, hesitancy, and financial constraints around completing LCS.

Conditions

• Lung Cancer

Interventions

BEHAVIORAL

Text Messages (TM+)

Basic text messages sent directly to the patient's cell phone.

BEHAVIORAL

Chat bot (CA)

Chat bot to answer frequently asked LCS questions.

BEHAVIORAL

Video

Educational video about LCS.

BEHAVIORAL

Reactive Patient Navigation (RPN)

Reactive patient navigation to help get to the LCS appointment.

BEHAVIORAL

Proactive Patient Navigation (PPN)

Proactive patient navigation to help get to the LCS appointment.

Sponsors & Collaborators

• Centers for Disease Control and Prevention

  collaborator FED

• University of Utah

  lead OTHER

Principal Investigators

• Chelsey Schlechter, MPH, PhD · Huntsman Cancer Institute

Study Design

Allocation

NON_RANDOMIZED

Purpose

PREVENTION

Masking

NONE

Model

SINGLE_GROUP

Eligibility

Min Age

50 Years

Max Age

80 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2026-01-01

Primary Completion

2027-01-31

Completion

2027-01-31

Countries

• United States

Study Locations